Abstract
Staphylococcus aureus isolates were screened for reduced susceptibility to glycopeptides with an initial glycopeptide agar screening test, followed by confirmation of the strains thus identified by two Etest strip techniques and population analysis. This procedure detected 48 methicillin-resistant S. aureus (MRSA) isolates with reduced susceptibility to glycopeptides from 24 patients among 883 MRSA isolates tested. The dissemination of a single clone was confirmed by pulsed-field gel electrophoresis.
MeSH terms
-
Anti-Bacterial Agents / pharmacology*
-
Anti-Bacterial Agents / therapeutic use
-
Disease Outbreaks*
-
France / epidemiology
-
Humans
-
Methicillin Resistance*
-
Staphylococcal Infections / drug therapy
-
Staphylococcal Infections / epidemiology*
-
Staphylococcal Infections / microbiology
-
Staphylococcus aureus / drug effects
-
Staphylococcus aureus / isolation & purification*
-
Teicoplanin / pharmacology
-
Teicoplanin / therapeutic use
-
Vancomycin / pharmacology
-
Vancomycin / therapeutic use
Substances
-
Anti-Bacterial Agents
-
Teicoplanin
-
Vancomycin